The Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia.
Department of Immunology, Flinders University and SA Pathology, Bedford Park, SA 5042, Australia.
Cell. 2020 Mar 5;180(5):878-894.e19. doi: 10.1016/j.cell.2020.01.029. Epub 2020 Feb 13.
Pathogenic autoantibodies arise in many autoimmune diseases, but it is not understood how the cells making them evade immune checkpoints. Here, single-cell multi-omics analysis demonstrates a shared mechanism with lymphoid malignancy in the formation of public rheumatoid factor autoantibodies responsible for mixed cryoglobulinemic vasculitis. By combining single-cell DNA and RNA sequencing with serum antibody peptide sequencing and antibody synthesis, rare circulating B lymphocytes making pathogenic autoantibodies were found to comprise clonal trees accumulating mutations. Lymphoma driver mutations in genes regulating B cell proliferation and V(D)J mutation (CARD11, TNFAIP3, CCND3, ID3, BTG2, and KLHL6) were present in rogue B cells producing the pathogenic autoantibody. Antibody V(D)J mutations conferred pathogenicity by causing the antigen-bound autoantibodies to undergo phase transition to insoluble aggregates at lower temperatures. These results reveal a pre-neoplastic stage in human lymphomagenesis and a cascade of somatic mutations leading to an iconic pathogenic autoantibody.
在许多自身免疫性疾病中都会产生致病自身抗体,但人们尚不清楚产生这些抗体的细胞是如何逃避免疫检查点的。在这里,单细胞多组学分析表明,在形成负责混合性冷球蛋白血症性血管炎的公共类风湿因子自身抗体的过程中,存在与淋巴恶性肿瘤相同的机制。通过将单细胞 DNA 和 RNA 测序与血清抗体肽测序和抗体合成相结合,发现产生致病性自身抗体的稀有循环 B 淋巴细胞构成了积累突变的克隆树。在产生致病性自身抗体的流氓 B 细胞中存在调节 B 细胞增殖和 V(D)J 突变(CARD11、TNFAIP3、CCND3、ID3、BTG2 和 KLHL6)的淋巴瘤驱动基因突变。抗体 V(D)J 突变通过导致抗原结合的自身抗体在较低温度下发生相变为不溶性聚集体而赋予致病性。这些结果揭示了人类淋巴瘤发生中的前肿瘤阶段和导致标志性致病性自身抗体的级联体细胞突变。